Pacific RxTracts - August 2025

Articles: Ready. Set. Infuse: TYZAVAN Brings Vancomycin Closer to the Bedside ENFLONSIA: A New Era in RSV Prevention for Infants A Shot for Peace of Mind: Can Yeztugo Eliminate the Risk of Contracting HIV? Ekterly: The First Orally Administered On-Demand HAE Treatment Autologous Chimeric Antigen Receptor CAR T cell Immunotherapy Risk Evaluation and Mitigation Strategies Removed Early Tirofiban Intervention Lowers Likelihood of Disability Post-Stroke Obicetrapib in High Risk Patients: A New Chapter in Cholesterol Management Lorundrostat for Uncontrolled Hypertension: Phase 3 Clinical Trial The Potential of Cagrilintide/Semaglutide (CagriSema) in Weight Management The Unfortunate Link Between GLP-1 RAs and Neovascular Macular Degeneration Efsitora: A New Approach to Insulin for Type Two Diabetics Maintaining Potassium Homeostasis: Potential Hidden Perk of SGLT2is Upadacitinib: A Promising Advance in Giant-Cell Arteritis Management FDA’s Commissioner’s National Priority Voucher: A New Approach to Strategic Drug Development Potential Liver Indication for SGLT2 Inhibitors Unexpected Protection: How the Meningococcal Vaccine May Prevent Gonorrhea Beyond Monoamines: Exploring KV7 Channel Modulator Azetukalner in MDD Limertinib: A Promising First-Line Treatment for Non-Small Cell Lung Cancer Camizestrant Outperforms Aromatase Inhibitors in ESR1-Mutated ER+/HER2- Advanced Breast Cancer: A Phase 3 SERENA-6 Study